Skip to content

Exercise, Cognitive Function and Neuroplasticity in Healthy Adults

Exercise, Cognitive Function and Neuroplasticity in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02994134
Enrollment
19
Registered
2016-12-15
Start date
2017-09-29
Completion date
2021-10-31
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary Lifestyle

Brief summary

The overall goal of the proposed study is to compare the effects of 4 weeks of moderate or high intensity aerobic exercise on neuroplasticity, cognitive performance and gait and postural control in sedentary healthy adults.

Detailed description

The primary aim of the study is to compare the effects of a moderate intensity aerobic exercise intervention (delivered at 55-64% age-predicted maximal heart rate) with a high intensity aerobic exercise intervention (delivered at 65%-90% age-predicted maximal heart rate) on measures that probe cortical synaptic plasticity using transcranial magnetic stimulation (TMS) in sedentary healthy adults.

Interventions

BEHAVIORALModerate intensity exercise.

Moderate intensity aerobic exercise intervention (delivered at 55-64% age-predicted maximal heart rate), 4 times per week for 4 weeks.

BEHAVIORALHigh intensity exercise.

High intensity aerobic exercise intervention (delivered at 65-90% age-predicted maximal heart rate), 4 times per week for 4 weeks.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males and females aged 18-70 years old * Primary language is English * Sedentary (defined as not engaging in purposeful physical activity more than 2 times over the last two months) * Exercise clearance

Exclusion criteria

* Presence of cognitive, neurologic or orthopedic conditions that could affect performance of the testing and training procedures * History of migraines. * History of fainting spells of unknown or undetermined etiology that might constitute seizures * History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG or family history of treatment resistant epilepsy * Any current history of a psychiatric illness * Any unstable medical condition * No medication is an absolute exclusion from TMS. Medications will be reviewed by the Principal Investigator and a decision about inclusion will be made based on the following: * The subject's past medical history, drug dose, history of recent medication changes or duration of treatment, and combination with other CNS active drugs. * The published TMS guidelines review medications to be considered with TMS (Rossi, Hallett, Rossini, Pascual-Leone, & Safety of TMS Consensus Group, 2009). * Any metal in the brain, skull or elsewhere unless approved by the responsible MD * Any medical devices (i.e. Cardiac pacemaker, deep brain stimulator, medication infusion pump, cochlear implant, vagal nerve stimulator) * Intracranial lesion * Substance abuse or dependence within the past six months Subjects who, in the Investigator's opinion, might not be suitable for the study

Design outcomes

Primary

MeasureTime frameDescription
Change in cortical synaptic plasticity using transcranial magnetic stimulation (TMS) from baseline to post-exercise.Baseline, 4 weeksPlasticity with TMS

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026